JP2023536883A5 - - Google Patents
Info
- Publication number
- JP2023536883A5 JP2023536883A5 JP2023507428A JP2023507428A JP2023536883A5 JP 2023536883 A5 JP2023536883 A5 JP 2023536883A5 JP 2023507428 A JP2023507428 A JP 2023507428A JP 2023507428 A JP2023507428 A JP 2023507428A JP 2023536883 A5 JP2023536883 A5 JP 2023536883A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- concentration
- aav particles
- pharmaceutical composition
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063063128P | 2020-08-07 | 2020-08-07 | |
| US202063063108P | 2020-08-07 | 2020-08-07 | |
| US63/063,108 | 2020-08-07 | ||
| US63/063,128 | 2020-08-07 | ||
| PCT/US2021/044955 WO2022032104A1 (en) | 2020-08-07 | 2021-08-06 | Formulations for highly purified viral particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536883A JP2023536883A (ja) | 2023-08-30 |
| JP2023536883A5 true JP2023536883A5 (enExample) | 2024-08-14 |
Family
ID=80114720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507428A Pending JP2023536883A (ja) | 2020-08-07 | 2021-08-06 | 高度に精製されたウイルス粒子のための製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220040305A1 (enExample) |
| EP (1) | EP4192437A4 (enExample) |
| JP (1) | JP2023536883A (enExample) |
| KR (1) | KR20230049670A (enExample) |
| CN (1) | CN116323925A (enExample) |
| AU (1) | AU2021320395A1 (enExample) |
| CA (1) | CA3190596A1 (enExample) |
| IL (1) | IL300323A (enExample) |
| MX (1) | MX2023001411A (enExample) |
| WO (1) | WO2022032104A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116096867A (zh) * | 2020-06-02 | 2023-05-09 | 詹森生物科技公司 | 用于病毒纯化的材料和方法 |
| US20230090654A1 (en) * | 2021-08-24 | 2023-03-23 | Homology Medicines, Inc. | Adeno-associated virus formulations |
| EP4651883A1 (en) * | 2023-01-19 | 2025-11-26 | uniQure biopharma B.V. | Pharmaceutical formulations of gene delivery vehicles |
| KR20260019635A (ko) * | 2023-06-09 | 2026-02-10 | 사르토리우스 비아이에이 세퍼레이션스 디.오.오. | 완전 충전 아데노 관련 바이러스 (aav) 캡시드의 향상된 분리 방법 |
| WO2025045083A1 (zh) * | 2023-09-01 | 2025-03-06 | 康霖生物科技（杭州）有限公司 | 一种液体制剂及其用途 |
| WO2025114524A1 (en) * | 2023-11-30 | 2025-06-05 | Uniqure Biopharma B.V. | Formulations for viral drug products |
| CN118957152B (zh) * | 2024-08-30 | 2025-11-25 | 浙江恒驭生物科技有限公司 | 一种腺相关病毒载体基因组滴度检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5118798B2 (ja) * | 2000-03-07 | 2013-01-16 | メルク・シャープ・エンド・ドーム・コーポレイション | アデノウイルス製剤 |
| BRPI0511764B8 (pt) * | 2004-06-01 | 2021-05-25 | Avigen Inc | método de prevenção de agregação de vírions de vírus adeno-associado recombinante (raav) em uma preparação purificada de virions raav |
| GB201513010D0 (en) * | 2015-07-23 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel formulation |
| IL258005B2 (en) * | 2015-09-17 | 2025-01-01 | Res Inst Nationwide Childrens Hospital | Methods and materials for gene therapy for beta-4,1-N-acetylgalactosaminyltransferase 2 |
| US12070702B2 (en) * | 2018-06-14 | 2024-08-27 | Regenxbio Inc. | Anion exchange chromatography for recombinant AAV production |
| CN112770812A (zh) * | 2018-07-24 | 2021-05-07 | 沃雅戈治疗公司 | 产生基因治疗制剂的系统和方法 |
| TW202332458A (zh) * | 2019-04-19 | 2023-08-16 | 美商銳進科斯生物股份有限公司 | 腺相關病毒載體調配物及方法 |
-
2021
- 2021-08-06 CA CA3190596A patent/CA3190596A1/en active Pending
- 2021-08-06 IL IL300323A patent/IL300323A/en unknown
- 2021-08-06 US US17/396,090 patent/US20220040305A1/en not_active Abandoned
- 2021-08-06 WO PCT/US2021/044955 patent/WO2022032104A1/en not_active Ceased
- 2021-08-06 AU AU2021320395A patent/AU2021320395A1/en not_active Abandoned
- 2021-08-06 EP EP21853878.3A patent/EP4192437A4/en active Pending
- 2021-08-06 CN CN202180067655.9A patent/CN116323925A/zh active Pending
- 2021-08-06 MX MX2023001411A patent/MX2023001411A/es unknown
- 2021-08-06 KR KR1020237007796A patent/KR20230049670A/ko not_active Withdrawn
- 2021-08-06 JP JP2023507428A patent/JP2023536883A/ja active Pending
-
2025
- 2025-11-04 US US19/379,616 patent/US20260061059A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536883A5 (enExample) | ||
| JP7531654B2 (ja) | アデノ随伴ウイルス精製方法 | |
| US12351832B2 (en) | Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography | |
| EP3256574B1 (en) | Recombinant adeno-associated virus particle purification comprising an affinity purification step | |
| JP5268890B2 (ja) | Ａａｖの規模適応性の製造方法 | |
| TWI886135B (zh) | 腺相關病毒純化方法 | |
| JP2021087431A5 (enExample) | ||
| JP2021530548A5 (enExample) | ||
| JP2022516283A5 (enExample) | ||
| JP2022549380A5 (enExample) | ||
| CN111032176A (zh) | Aav载体柱纯化方法 | |
| JP2022547197A5 (enExample) | ||
| JP2022533448A5 (enExample) | ||
| RU2785661C2 (ru) | Способы очистки аденоассоциированных вирусов | |
| CA2975569C (en) | Recombinant adeno-associated virus particle purification comprising an affinity purification step | |
| HK1227436A1 (en) | Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography |